|
WO03016504A2
|
|
Polymorphisms associated with ion-channel disease
|
|
WO02068448A1
|
|
Method for evaluating the ability to metabolize pharmaceuticals and compositions therefor
|
|
WO0239084A2
|
|
Variable geometry fluid sample loader
|
|
WO0225243A1
|
|
Sample injector system and method
|
|
US2002060153A1
|
|
Microchannel turn design
|
|
AU7521301A
|
|
A method and system for populating a database
|
|
WO0194546A2
|
|
Primer extension using a mixture of labelled and unlabelled nucleotides
|
|
AU5913101A
|
|
Detection of nucleotide sequence variations via the proofreading activity of polymerases
|
|
AU4581101A
|
|
Database system and method
|
|
AU4554901A
|
|
Cross channel device for serial sample injection
|
|
AU4540501A
|
|
Polymorphisms associated with insulin-signaling and glucose-transport pathways
|
|
AU4173301A
|
|
Methods for determining single nucleotide variations
|
|
AU1939001A
|
|
Methods for determining single nucleotide variations and genotyping
|
|
US6355433B1
|
|
Determination of nucleotide sequence variations through limited primer extension
|
|
US6573047B1
|
|
Detection of nucleotide sequence variation through fluorescence resonance energy transfer label generation
|
|
CA2350069A1
|
|
Methods to reduce variance in treatment studies using genotyping
|
